Sleeping Through a Pandemic
MedPage Today: Three distinct profiles of sleep changes are seen in the general population during COVID-19.
Tag: SLEEP 2020
All
Latest
All
Latest
How Machine Learning Could Transform the Way We Diagnose Narcolepsy
Machine learning and the use of neural network analysis could speed up the diagnostic process, and pave the way for more precise care.
All
LatestSorry, No Posts Found
How Does Sleep Loss Impact Criminal Interrogations?
There was little direct, scientific evidence on whether sleep enhances or inhibits intelligence disclosures prior to this study.
Read MoreJazz Presents New Data on Xywav & Sunosi at Virtual SLEEP 2020
Highlights include presentations on Xywav, a lower sodium oxybate iindicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Read MoreHarmony Presents New WAKIX Data at Virtual SLEEP 2020
The data include a final analysis of the Pitolisant Expanded Access Clinical Evaluation Program, two post-hoc analyses on clinically relevant outcomes from the Phase 3 clinical trials, and analyses that further characterize the cardiac safety profile of WAKIX.
Read MoreEisai Presents Latest Insomnia Research at Virtual SLEEP 2020
Highlights include an oral presentation focusing on the long-term efficacy and safety of DAYVIGO in adults ages 65 and older with insomnia disorder from the Phase 3 clinical study.
Read More
Can Virtual Reality Help Teens Fall Asleep Faster?
On the intervention night, study participants performed slow breathing while experiencing a relaxing, immersive, virtual reality environment.
Read More
First Episode of REM Takes Almost 1.5X Longer to Reach for Astronauts on Space Station
“There were marked shifts in sleep architecture compared to baseline, and some of these evolved over the course of the mission,” says lead author Oliver Piltch.
Read MorePhase 3 Study Results of Investigational Dual Orexin Receptor Antagonist for Insomnia to Be Presented at SLEEP 2020
Idorsia Ltd reports positive results from the first pivotal Phase 3 study investigating 25 and 50 mg doses of its dual orexin receptor antagonist, daridorexant, in adult and elderly patients with insomnia.
Read More
8 Anticipated Highlights of Virtual SLEEP 2020
A plenary session will discuss sleep and Alzheimer’s disease. Blues Night will be a tribute to Bill Dement, MD, PhD.
Read More2-Year Study Confirms Favorable Safety Profile of REMFresh Over-the-Counter Melatonin
Findings from REMSU24 are consistent with the outcomes from REMSU12, reaffirming the safety and tolerability profile of REMfresh in a real-world setting.
Read More
Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?
A new study finds about 20% of restless legs syndrome patients are prescribed doses above the recommended maximum.
Read More
Deadline to Submit COVID-19 Session Proposals to Virtual SLEEP 2020
The deadline to submit session proposals for the Virtual SLEEP 2020 meeting, specific to clinical efforts and findings related to COVID-19 and sleep, is Monday, June 8, according to the Associated Professional Sleep Societies (APSS).
Read More
SLEEP 2020 is Going Virtual
Due to the COVID-19 pandemic, one of the largest sleep medicine events in North America, the SLEEP 2020 meeting, will go virtual for the first time.
Read More
Registration Suspended: SLEEP 2020 Could Transition to Virtual Meeting
The Associated Professional Sleep Societies, LLC (APSS) is suspending registration for SLEEP 2020 while continuing contract negotiations with the city of Philadelphia on a plan to host the SLEEP meeting there in a future year, according to a statement.
Read More
Updates: Coronavirus Impacts Sleep Medicine Conferences
AADSM Meeting Canceled; SLEEP 2020 Will Go Forward
Read More